Beijing Tiantan Biological Products Corp Ltd (600161) — Cash Flow Quality Index
Beijing Tiantan Biological Products Corp Ltd (600161) has a Cash Flow Quality Index of 1.71x as of September 2025. Operating cash flow of CN¥318.80 Million exceeds net income of CN¥186.12 Million, indicating high earnings quality where cash backs reported profits. Explore Beijing Tiantan Biological Products Corp (600161) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Tiantan Biological Products Corp Ltd Cash Flow Quality Index (1998–2024)
Historical Cash Flow Quality Index for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 600161 operating cash flow.
Annual Cash Flow Quality Index for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year earnings quality comparison for Beijing Tiantan Biological Products Corp Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.39x | CN¥819.78 Million | CN¥2.11 Billion | ▼ -75.5% |
| 2023 | 1.59x | CN¥2.39 Billion | CN¥1.51 Billion | ▲ +69.7% |
| 2022 | 0.93x | CN¥1.13 Billion | CN¥1.20 Billion | ▲ +1.9% |
| 2021 | 0.92x | CN¥980.35 Million | CN¥1.07 Billion | ▲ +23.2% |
| 2020 | 0.74x | CN¥702.11 Million | CN¥943.08 Million | ▲ +3.6% |
| 2019 | 0.72x | CN¥642.47 Million | CN¥894.25 Million | ▼ -22.0% |
| 2018 | 0.92x | CN¥677.92 Million | CN¥735.90 Million | ▲ +425.6% |
| 2017 | 0.18x | CN¥218.39 Million | CN¥1.25 Billion | ▼ -87.6% |
| 2016 | 1.41x | CN¥428.37 Million | CN¥303.01 Million | ▼ -65.5% |
| 2015 | 4.09x | CN¥473.26 Million | CN¥115.58 Million | ▲ +93.7% |
| 2014 | 2.11x | CN¥477.95 Million | CN¥226.16 Million | ▲ +72.2% |
| 2013 | 1.23x | CN¥566.43 Million | CN¥461.48 Million | ▲ +5.1% |
| 2012 | 1.17x | CN¥432.00 Million | CN¥369.96 Million | ▼ -3.5% |
| 2011 | 1.21x | CN¥353.15 Million | CN¥291.84 Million | ▲ +46.2% |
| 2010 | 0.83x | CN¥184.85 Million | CN¥223.35 Million | ▼ -48.3% |
| 2009 | 1.60x | CN¥448.23 Million | CN¥280.18 Million | ▲ +13.0% |
| 2008 | 1.42x | CN¥276.39 Million | CN¥195.28 Million | ▲ +37.6% |
| 2007 | 1.03x | CN¥153.55 Million | CN¥149.32 Million | ▼ -30.2% |
| 2006 | 1.47x | CN¥154.36 Million | CN¥104.83 Million | ▼ -22.8% |
| 2005 | 1.91x | CN¥131.69 Million | CN¥69.00 Million | ▼ -17.6% |
| 2004 | 2.32x | CN¥110.11 Million | CN¥47.53 Million | ▲ +59.1% |
| 2003 | 1.46x | CN¥62.93 Million | CN¥43.23 Million | ▼ -37.4% |
| 2002 | 2.32x | CN¥84.38 Million | CN¥36.30 Million | ▲ +71.7% |
| 2001 | 1.35x | CN¥46.49 Million | CN¥34.35 Million | ▲ +7.3% |
| 2000 | 1.26x | CN¥47.90 Million | CN¥37.97 Million | ▲ +28.0% |
| 1999 | 0.99x | CN¥42.58 Million | CN¥43.20 Million | ▲ +39.6% |
| 1998 | 0.71x | CN¥23.71 Million | CN¥33.58 Million | — |